Evidence map›Paper›PMID 33108692›Full record

ArticleAnnals of clinical and translational neurology2020

Tau pathology associates with in vivo cortical thinning in Lewy body disorders.

Nicola Spotorno, David G Coughlin, Christopher A Olm, David Wolk, Sanjeev N Vaishnavi, Leslie M Shaw, Nabila Dahodwala, James F Morley, John E Duda, Andres F Deik and 8 more

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Where do PDD and DLB SYNdromes fit in neuronal alpha-SYNuclein biological frameworks?Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  3. Article
  4. Regional cortical network atrophy predicts progression to dementia in the Lewy body diseases.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Polypathologic Associations with Gray Matter Atrophy in Neurodegenerative Disease.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  11. Article
  12. Mild cognitive impairment in dementia with Lewy bodies: an update and outlook.Journal of neural transmission (Vienna, Austria : 1996) · 2023
    Review
  13. Dementia with Lewy bodies: Impact of co-pathologies and implications for clinical trial design.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023
    Review
  14. Article
  15. Article
  16. Longitudinal Tau Positron Emission Tomography in Dementia with Lewy Bodies.Movement disorders : official journal of the Movement Disorder Society · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. LateralizedAlzheimer's & dementia (New York, N. Y.) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Nicola SpotornoPenn Frontotemporal Degeneration Center, Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.ORCID 0000-0001-5404-8788
David G CoughlinDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania Philadelphia, Philadelphia, PA, USA.
Christopher A OlmPenn Frontotemporal Degeneration Center, Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
David WolkDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania Philadelphia, Philadelphia, PA, USA.
Sanjeev N VaishnaviDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania Philadelphia, Philadelphia, PA, USA.
Leslie M ShawDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Nabila DahodwalaDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania Philadelphia, Philadelphia, PA, USA.
James F MorleyDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania Philadelphia, Philadelphia, PA, USA.
John E DudaDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania Philadelphia, Philadelphia, PA, USA.
Andres F DeikDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania Philadelphia, Philadelphia, PA, USA.
Meredith A SpindlerDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania Philadelphia, Philadelphia, PA, USA.
Alice Chen-PlotkinDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania Philadelphia, Philadelphia, PA, USA.
Edward B LeeAlzheimer's Disease Center, Department of Neuropathology Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
John Q TrojanowskiAlzheimer's Disease Center, Department of Neuropathology Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Corey T McMillanPenn Frontotemporal Degeneration Center, Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Daniel WeintraubDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania Philadelphia, Philadelphia, PA, USA.ORCID 0000-0003-0633-7168
Murray GrossmanPenn Frontotemporal Degeneration Center, Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
David J IrwinPenn Frontotemporal Degeneration Center, Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.ORCID 0000-0002-5599-5098
University of Pennsylvania · USAlzheimer’s Disease Neuroimaging Initiative · USVeterans Health Administration · USUC San Diego Health System · US

Funding

Transgenic Mouse Models of Tau PathologiesP01AG017586 · NIA · UNIVERSITY OF PENNSYLVANIA · PI LEE, VIRGINIA M · 2000 to 2021
$37.3M
UPenn ADCC Biomarker CoreP30AG010124 · NIA · UNIVERSITY OF PENNSYLVANIA · PI XIE, SHARON XIANGWEN · 1991 to 2020
$35.1M
UCSD Shiley-Marcos Alzheimer's Disease Research Center P30P30AG062429 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Steven Dyal Edland · 2019 to 2026
$34.9M
Project IV: "Alpha-Synuclein Strains & Diverse Synucleinopathies"P50NS053488 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI TROJANOWSKI, JOHN Q. · 2007 to 2017
$20.9M
Understanding Environmental Contributions to Heterogeneity in bvFTD.P01AG066597 · NIA · UNIVERSITY OF PENNSYLVANIA · PI David John Irwin, Corey T McMillan · 2020 to 2026
$18.8M
Project IV "Tackling Heterogeneity of Cognitive Trajectory in LBD"U19AG062418 · NIA · UNIVERSITY OF PENNSYLVANIA · PI TROJANOWSKI, JOHN Q. · 2019 to 2023
$18.1M
Spreading Tau Pathology in Non-Amnestic Alzheimer's DiseaseR01AG054519 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jeffrey S Phillips · 2018 to 2026
$7.4M
NIA NIH HHS P01 AG017586NIA NIH HHS P01 AG066597NIA NIH HHS P30 AG010124NIA NIH HHS P30 AG062429NIA NIH HHS R01 AG054519NIA NIH HHS U19 AG062418NINDS NIH HHS P50 NS053488
6 · The paper itself

Abstract

objectivesTo investigate the impact of Alzheimer's disease (AD) co-pathology on an in vivo structural measure of neurodegeneration in Lewy body disorders (LBD).

methodsWe studied 72 LBD patients (Parkinson disease (PD) = 2, PD-MCI = 25, PD with dementia = 10, dementia with Lewy bodies = 35) with either CSF analysis or neuropathological examination and structural MRI during life. The cohort was divided into those harboring significant AD co-pathology, either at autopsy (intermediate/high AD neuropathologic change) or with CSF signature indicating AD co-pathology (t-tau/Aβ

resultsThe LBD+AD group was characterized by cortical thinning in anterior/medial and lateral temporal regions (P < 0.05 FWE-corrected) relative to LBD-AD. In LBD+AD, cortical thinning was most pronounced in temporal neocortex, whereas the AD reference group showed atrophy that equally encompassed temporal, parietal and frontal neocortex. In autopsied LBD, we found an inverse correlation with cortical thickness and post-mortem tau pathology, while cortical thickness was not significantly associated with Aβ or alpha-synuclein pathology.

interpretationLBD+AD is characterized by temporal neocortical thinning on MRI, and cortical thinning directly correlated with post-mortem histopathologic burden of tau, suggesting that tau pathology influences the pattern of neurodegeneration in LBD.

Indexed as

Alzheimer DiseaseCognitive DysfunctionDementiaLewy Body DiseaseParkinson DiseaseAgedAutopsyComorbidityFemaleHumansMaleMiddle AgedNeocortexRetrospective Studiestau Proteinstau Proteins

Identifiers

PMID33108692
PMCPMC7732256
OpenAlexW3096349182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.